Image pharmaphorum Editor News Migraine prevention drug Aimovig poised for EU approval The first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval. News AZ's Imfinzi hits second lung cancer trial goal But AZ is anxiously waiting for results of MYSTIC trial Digital Sponsored How to make digital work in medtech Overview The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech. News LuViva scanner could provide alternative to smear test Device is 18 months from US approval Load more results
News Migraine prevention drug Aimovig poised for EU approval The first antibody treatment to prevent migraine (Aimovig), produced by Novartis, is on the cusp of approval.
News AZ's Imfinzi hits second lung cancer trial goal But AZ is anxiously waiting for results of MYSTIC trial
Digital Sponsored How to make digital work in medtech Overview The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.